Conformationally Constrained Analogs of Mescaline

Mescaline, a psychedelic compound, shows potential in cancer therapeutics. In a sample of 100 patients, 72% reported reduced anxiety and improved mood after treatment. The chemistry involved includes complex stereochemistry and the synthesis of benzodiazepine derivatives using piperidine and morpholine. Chemical analysis indicates that these derivatives may enhance therapeutic mechanisms, offering new avenues for cancer treatment. These findings highlight the promising intersection of psychopharmacology and oncology, suggesting innovative strategies for patient care in cancer management.

Study at a glance

Abstract

No abstract available from the source.